Q1 FY2025 saw record revenue and profit growth, driven by strong electronic medical record system sales and cost controls. Both order intake and backlog hit all-time highs, and full-year guidance remains unchanged, with a higher dividend forecast.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.